U.S. flag

An official website of the United States government

NM_022436.3(ABCG5):c.593G>A (p.Arg198Gln) AND Cardiovascular phenotype

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
May 25, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003298337.9

Allele description [Variation Report for NM_022436.3(ABCG5):c.593G>A (p.Arg198Gln)]

NM_022436.3(ABCG5):c.593G>A (p.Arg198Gln)

Genes:
ABCG5:ATP binding cassette subfamily G member 5 [Gene - OMIM - HGNC]
DYNC2LI1:dynein cytoplasmic 2 light intermediate chain 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p21
Genomic location:
Preferred name:
NM_022436.3(ABCG5):c.593G>A (p.Arg198Gln)
Other names:
p.Arg198Gln
HGVS:
  • NC_000002.12:g.43828024C>T
  • NG_008883.1:g.15796G>A
  • NG_008884.2:g.1083C>T
  • NG_053008.1:g.58986C>T
  • NM_001348912.2:c.*654C>T
  • NM_001348913.2:c.*654C>T
  • NM_022436.3:c.593G>AMANE SELECT
  • NP_071881.1:p.Arg198Gln
  • LRG_1181t1:c.593G>A
  • LRG_1181:g.15796G>A
  • LRG_1181p1:p.Arg198Gln
  • LRG_1182:g.1083C>T
  • NC_000002.11:g.44055163C>T
  • NM_022436.2:c.593G>A
Protein change:
R198Q
Links:
dbSNP: rs141828689
NCBI 1000 Genomes Browser:
rs141828689
Molecular consequence:
  • NM_001348912.2:c.*654C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001348913.2:c.*654C>T - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_022436.3:c.593G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Cardiovascular phenotype
Identifiers:
MedGen: CN230736

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV003999274Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(May 25, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

ABCG5/G8 gene is associated with hypercholesterolemias without mutation in candidate genes and noncholesterol sterols.

Lamiquiz-Moneo I, Baila-Rueda L, Bea AM, Mateo-Gallego R, Pérez-Calahorra S, Marco-Benedí V, Martín-Navarro A, Ros E, Cofán M, Rodríguez-Rey JC, Pocovi M, Cenarro A, Civeira F.

J Clin Lipidol. 2017 Nov-Dec;11(6):1432-1440.e4. doi: 10.1016/j.jacl.2017.09.005. Epub 2017 Oct 4.

PubMed [citation]
PMID:
29066094

Targeted exome sequencing in South Indian patients with Familial hypercholesterolemia.

Pillai KKB, Shah SAV, Reddy LL, Ashavaid TF, Vishwanathan S.

Clin Chim Acta. 2022 Feb 15;527:47-55. doi: 10.1016/j.cca.2021.12.022. Epub 2022 Jan 6.

PubMed [citation]
PMID:
34998859
See all PubMed Citations (3)

Details of each submission

From Ambry Genetics, SCV003999274.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

The p.R198Q variant (also known as c.593G>A), located in coding exon 5 of the ABCG5 gene, results from a G to A substitution at nucleotide position 593. The arginine at codon 198 is replaced by glutamine, an amino acid with highly similar properties. This alteration has been reported as heterozygous in familial hypercholesterolemia cohorts (Lamiquiz-Moneo I et al. J Clin Lipidol, 2017 Oct;11:1432-1440.e4; Pillai KKB et al. Clin Chim Acta, 2022 Feb;527:47-55; Rutkowska L et al. Genes (Basel), 2022 Jun;13:[ePub ahead of print]). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jan 19, 2025